J05AJ Integrase Inhibitors, antiinfectives for systematic use
ATC class of level 4 – chemical subgroup
This page lists the patient medication information or the product monograph for 9 drugs in this drug class and its subclasses.
- 9 prescription (Rx)
Place in the ATC system
- J Antiinfectives for systemic use 1,101 drugs
- J05 Antivirals for systemic use 246 drugs
- J05A Direct acting antivirals 246 drugs
-
J05AJ Integrase Inhibitors, antiinfectives for systematic use 9 drugs
- J05AJ01 Raltegravir 2 drugs
- J05AJ02 Elvitegravir 1 drug
- J05AJ03 Dolutegravir 4 drugs
- J05AJ04 Cabotegravir 2 drugs
-
J05AJ Integrase Inhibitors, antiinfectives for systematic use 9 drugs
- J05A Direct acting antivirals 246 drugs
- J05 Antivirals for systemic use 246 drugs
Active ingredients of the class
- Cabotegravir 1 drug
- Cabotegravir (cabotegravir sodium) 2 drugs
- Dolutegravir (dolutegravir sodium) 4 drugs
- Elvitegravir 1 drug
- Raltegravir (raltegravir potassium) 2 drugs
Drugs in the class and its subclasses
| Drug | Rx or OTC |
|---|---|
| Apretude (J05AJ04 Cabotegravir) | prescription (Rx) |
| Isentress (Merck Canada, 25 mg, 100 mg) (J05AJ01 Raltegravir) | prescription (Rx) |
| Isentress (Merck Canada, 400 mg, 600 mg) PM (J05AJ01 Raltegravir) | prescription (Rx) |
| PMS-Dolutegravir PM (J05AJ03 Dolutegravir) | prescription (Rx) |
| Sandoz Dolutegravir PM (J05AJ03 Dolutegravir) | prescription (Rx) |
| Tivicay (Viiv Healthcare, 10 mg, 25 mg) PM (J05AJ03 Dolutegravir) | prescription (Rx) |
| Tivicay (Viiv Healthcare, 50 mg, 5 mg) PM (J05AJ03 Dolutegravir) | prescription (Rx) |
| Vitekta PM (J05AJ02 Elvitegravir) | prescription (Rx) |
| Vocabria PM (J05AJ04 Cabotegravir) | prescription (Rx) |
Other classes of the same level
- J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 73 drugs
- J05AD Phosphonic acid derivatives, direct acting antivirals 1 drug
- J05AE Protease inhibitors, direct acting antivirals 28 drugs
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 42 drugs
- J05AG Non-nucleoside reverse transcriptase inhibitors 14 drugs
- J05AH Neuraminidase inhibitors, direct acting antivirals 10 drugs
- J05AP Antivirals for treatment of HCV infections 16 drugs
- J05AR Antivirals for treatment of HIV infections, combinations 40 drugs
- J05AX Other antivirals 13 drugs
Other names of the drug class
- English (United Kingdom): J05AJ Integrase Inhibitors, antiinfectives for systematic use
- German: J05AJ Integrase-Inhibitoren
- German (Austria): J05AJ Integrase-Inhibitoren
- Italian: J05AJ Inibitori dell'integrasi
- Turkish: J05AJ Integrase İnhibitörleri, sistematik kullanım için antienfektifler
- Czech: J05AJ Inhibitory integrázy
- German (Switzerland): J05AJ Integrase-Inhibitoren
- Italian (Switzerland): J05AJ Inibitori dell'integrasi
- Dutch: J05AJ Integraseremmers, anti-infectieuze middelen voor systemisch gebruik
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class J05AJ
Ask your doctor or pharmacist for advice.